Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 23, Issue 3, Pages 409-420
Publisher
Oxford University Press (OUP)
Online
2017-02-17
DOI
10.1097/mib.0000000000001025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis
- (2016) S. Singh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease
- (2016) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Anti-TNF Monotherapy for Crohn’s Disease: a 13-year Multicentre Experience
- (2016) Laurent Peyrin-Biroulet et al. Journal of Crohns & Colitis
- Long-Term Response Rates to Infliximab Therapy for Crohn’s Disease in an Outpatient Cohort
- (2016) Christopher W Teshima et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONICpost hocanalysis
- (2015) J.-F. Colombel et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
- (2015) Henit Yanai et al. Clinical Gastroenterology and Hepatology
- Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
- (2015) Glen S. Hazlewood et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
- (2015) Brian Bressler et al. GASTROENTEROLOGY
- Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn’s Disease
- (2015) Casper Steenholdt et al. Journal of Crohns & Colitis
- Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
- (2015) Konstantinos Papamichael WORLD JOURNAL OF GASTROENTEROLOGY
- The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
- (2014) Niels Vande Casteele et al. GUT
- Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
- (2014) Christopher Ma et al. Journal of Crohns & Colitis
- Comparative Efficacy of Biologic Therapy in Biologic-Naïve Patients With Crohn Disease: A Systematic Review and Network Meta-analysis
- (2014) Siddharth Singh et al. MAYO CLINIC PROCEEDINGS
- Time of infliximab therapy initiation and dose escalation in Crohn’s disease
- (2014) Mindy CW Lam WORLD JOURNAL OF GASTROENTEROLOGY
- Biological therapies in Crohn’s disease: are they cost-effective? A critical appraisal of model-based analyses
- (2014) Monia Marchetti et al. Expert Review of Pharmacoeconomics & Outcomes Research
- American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease
- (2013) Jonathan P. Terdiman et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
- (2012) Zuzana Zelinkova et al. Clinical Gastroenterology and Hepatology
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
- (2012) Mirthe Emilie van der Valk et al. GUT
- Implementing changes in clinical practice to improve the management of Crohn's disease
- (2012) Remo Panaccione et al. Journal of Crohns & Colitis
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies
- (2011) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Direct Medical Cost of Managing IBD Patients: A Canadian Population-based Study
- (2011) Charles N. Bernstein et al. INFLAMMATORY BOWEL DISEASES
- Long-term Durability of Infliximab Treatment in Crohnʼs Disease and Efficacy of Dose “Escalation” in Patients Losing Response
- (2011) María Chaparro et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Intensification of infliximab therapy in Crohn's disease: Efficacy and safety
- (2011) M.Chaparro et al. Journal of Crohns & Colitis
- Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis
- (2011) John Paul Leombruno et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
- (2010) Geert R D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
- (2010) Waqqas Afif et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab
- (2009) G. BOUGUEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
- (2009) Pál Miheller et al. BMC GASTROENTEROLOGY
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
- (2008) F Schnitzler et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now